S&P 500 Futures
(0.01%) 5 207.00 points
Dow Jones Futures
(0.06%) 39 020 points
Nasdaq Futures
(-0.17%) 18 165 points
Oil
(-0.25%) $78.28
Gas
(1.32%) $2.22
Gold
(-0.28%) $2 324.70
Silver
(-0.34%) $27.52
Platinum
(0.03%) $965.15
USD/EUR
(0.06%) $0.929
USD/NOK
(0.38%) $10.87
USD/GBP
(0.16%) $0.797
USD/RUB
(-0.12%) $91.23

Actualizaciones en tiempo real para Living Cell Technologies [LVCLY]

Bolsa: OTC Sector: Healthcare Industria: Biotechnology
Última actualización24 abr 2024 @ 14:28

0.00% $ 0.0427

Live Chart Being Loaded With Signals

Commentary (24 abr 2024 @ 14:28):

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand...

Stats
Volumen de hoy 45.00
Volumen promedio 2 721.00
Capitalización de mercado 12.27M
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -4.27
ATR14 $0 (0.00%)

Living Cell Technologies Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Living Cell Technologies Finanzas

Annual 2023
Ingresos: $42 016.00
Beneficio Bruto: $41 459.00 (98.67 %)
EPS: $-0.00160
FY 2023
Ingresos: $42 016.00
Beneficio Bruto: $41 459.00 (98.67 %)
EPS: $-0.00160
FY 2022
Ingresos: $3 405.00
Beneficio Bruto: $2 662.00 (78.18 %)
EPS: $-0.00220
FY 2021
Ingresos: $0.00
Beneficio Bruto: $0.00 (0.00 %)
EPS: $-0.0244

Financial Reports:

No articles found.

Living Cell Technologies

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico